01 Growing Shift Toward Nonthermal Endovenous Treatment Technologies The varicose vein treatment market is moving beyond conventional thermal ablation toward nonthermal approaches that can close diseased veins without delivering thermal energy to surrounding tissue. These techniques are expanding treatment choices for patients and physicians by offering alternative procedural approaches that may reduce dependence on tumescent anesthesia and heat-based treatment. In February 2026, researchers from Indira Gandhi Medical College published clinical outcomes for nonthermal, nontumescent cyanoacrylate glue ablation for symptomatic truncal vein disease, reflecting continued clinical evaluation of alternatives to thermal ablation.
02 Increasing Development of More Targeted Endovenous Ablation Techniques Treatment technologies are increasingly being refined to improve the precision of vein closure while addressing multiple diseased venous segments within minimally invasive procedures. This is encouraging the development of techniques designed to treat truncal veins, tributaries, and perforators with greater procedural control. In September 2026, a multicenter study reported early results for total endovenous laser ablation performed in a single session across truncal veins, tributaries, and perforators.
01 Increasing Diagnosis of Symptomatic Venous Reflux Expands Treatment Demand Greater clinical identification of venous reflux is supporting demand for interventions that restore normal venous blood flow and relieve symptoms such as pain, swelling, heaviness, and discomfort. Duplex ultrasound assessment helps clinicians identify the extent of reflux and determine appropriate treatment, creating a pathway from diagnosis to intervention.
01 Recurrence of Venous Disease Can Require Additional Treatment Sessions Varicose vein treatment does not eliminate the possibility of future venous reflux or development of additional varicosities. The potential need for retreatment can increase the overall treatment burden for patients and healthcare providers, particularly when disease involves multiple venous segments.
01 Expansion of Same-Day Minimally Invasive Venous Procedures Creates New Service Opportunities Healthcare providers are increasingly seeking procedural approaches that can shorten recovery and reduce the burden associated with conventional surgical treatment. Technologies that enable minimally invasive treatment with efficient post-procedure recovery can therefore support expansion of outpatient venous-care services.
01 Demonstrating Long-Term Durability Across Emerging Treatment Modalities Remains Difficult New ablation technologies must demonstrate sustained vein closure, symptom improvement, and acceptable complication rates over extended follow-up. Differences in anatomy, disease severity, procedural technique, and treatment modality can make it difficult to establish long-term comparative performance across competing interventions.
June 2026 Boston Scientific expanded its venous intervention portfolio with new technologies for minimally invasive treatment of chronic venous disease, improving procedural efficiency and patient recovery.
April 2026 Medtronic introduced enhancements to its vascular treatment portfolio, supporting endovenous procedures for varicose veins with improved catheter technology and procedural precision.
February 2026 Biolitec expanded its ELVeS® laser therapy platform with upgraded laser fibers designed to improve outcomes in endovenous laser treatment of varicose veins.
October 2025 AngioDynamics expanded physician training programs and commercial activities for its VenaCure EVLT™ system, supporting wider adoption of minimally invasive varicose vein treatment procedures.